
News|Slideshows|August 8, 2023
Updated CDC Immunization Guidelines for 2023-2024 Tripledemic Viruses
Author(s)Kenneth Bender, PharmD, MA
CDC immunization recommendations for influenza, COVID-19, and RSV from the updated 2023 schedules are summarized in this Guideline Topline.
Advertisement
The immunization schedules issued by the Centers for Disease Control and Prevention (CDC) in February 2023 contain several important updates, including recommending COVID-19 primary and booster vaccine series for the general population and individuals who are moderately to severely immunocompromised.
In advance of the 2023-2024 respiratory virus season, this Guideline Topline slide show summarizes updates regarding the 3 top respiratory viruses that could work up a tripledemic this year or could be equally menacing each on its own: influenza, COVID-19, and respiratory syncytial virus.
In addition to the CDC highlights, the summaries include recommendations from recent meetings of the CDC's Advisory Committee on Immunization Practices (ACIP) and the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC).All recommendations have been accepted by the CDC as official and either are, or will be posted in The Morbidity and Mortlity Weekly Report (MMWR).
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
This Year in Primary Care: 10 Critical Updates in 2025
2
Advancing Early Detection and Equitable Access in Alzheimer Disease Care
3
FDA Approves Abbott Volt Pulsed Field Ablation System for Treatment of Atrial Fibrillation
4
FDA Approves First Oral GLP-1 Receptor Agonist for Chronic Weight Management
5






























































































































































































































































































































